Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/6/2025

Hydrocodone Dosing for Hospice Patients with Pain

Initial Dosing and Titration

  • The CDC guidelines recommend starting with the lowest dose for opioid-naïve patients, often equivalent to a single dose of approximately 5-10 MME, and since hydrocodone has a 1:1 conversion to MME, a 5 mg dose falls within this recommended range, for patients with pain 1, 2
  • The European Society for Medical Oncology (ESMO) cancer pain guidelines recommend starting doses that align with the lower end of the spectrum for opioid-naïve patients, for patients with cancer pain 3, 4, 5
  • For patients ≥65 years or with renal/hepatic impairment, the CDC recommends considering using the 2.5 mg/325 mg formulation if available to allow for even more cautious titration, for patients with pain 1

Breakthrough Dosing and Safety Measures

  • The American Thoracic Society emphasizes that the correct dose is the dose that relieves the symptom, with no maximum doses of opioids in palliative care, for patients with respiratory symptoms 6, 7, 8
  • If more than 4 breakthrough doses are needed in 24 hours, the European Society for Medical Oncology (ESMO) recommends increasing the scheduled around-the-clock dose, for patients with cancer pain 4
  • Prescribe a stimulant laxative and stool softener prophylactically from the first dose, as constipation is predictable with opioids, according to the American Thoracic Society, for patients on opioids 6, 7
  • Offer naloxone and overdose prevention education to the patient and household members, as recommended by the CDC, for patients on opioids 1

Common Pitfalls to Avoid

  • Do not start with 10 mg in opioid-naïve patients—this unnecessarily increases overdose risk without evidence of superior pain control, according to the CDC guidelines, for patients with pain 1, 2
  • Do not use transdermal fentanyl for initial opioid therapy—it is inappropriate for rapid titration and should only be used for chronic stable pain, as recommended by the American Thoracic Society, for patients with respiratory symptoms 6, 7